Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tenatumomab"'
Autor:
Francesco Gasparrini, Omar H. Ismail, Alessia Ciogli, Giuseppe Pierri, Rita De Santis, Claudio Villani, Giulia Mazzoccanti, Fabrizio Giorgi
Publikováno v:
Separation Science Plus. 1:261-269
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75b0d0a1088c2602749ae7f2932a4bd0
https://doi.org/10.1002/sscp.201800002
https://doi.org/10.1002/sscp.201800002
Autor:
Ferdinando Maria Milazzo, Fiorella Petronzelli, Antonio Rosi, Rita De Santis, Gianfranco Battistuzzi, Anna Maria Anastasi, Giuseppe Giannini, Loredana Leone, Claudio Albertoni, Laura Salvini, Lorenzo Tei
Publikováno v:
Bioorganicmedicinal chemistry. 27(15)
Tenatumomab is an anti-tenascin murine monoclonal antibody previously used in clinical trials for delivering radionuclides to tumors by both pre-targeting (biotinylated Tenatumomab within PAGRIT) and direct 131Iodine labeling approaches. Here we pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7416f48710db6cf412130e85e1b8af87
https://pubmed.ncbi.nlm.nih.gov/31208798
https://pubmed.ncbi.nlm.nih.gov/31208798
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cristina Boschini, Fiorella Petronzelli, Giuseppe Gritti, Andrea Gianatti, Alessandro Rambaldi, Anna Maria Barbui, Riccardo L. Rossi, Rosangela Trezzi, Andrea Rossi
Publikováno v:
Blood. 128:4141-4141
Introduction: Tenascins are a family of large glycoproteins present in extracellular matrix, overexpressed in tumors compared to healthy tissues. Tenatumomab (ST2146) is an anti tenascin-C monoclonal antibody that is currently under development for r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07c5d36d49be19ce72b03172b105c19e
https://doi.org/10.1182/blood.v128.22.4141.4141
https://doi.org/10.1182/blood.v128.22.4141.4141